Healthcare Options See Hims, Moderna and Unilever Whale Activity
Benzinga reports significant options flow in Hims & Hers, Moderna, and Unilever, with Hims showing the largest single trade value at $232,400.
Key points
- Hims & Hers Health had the largest trade value at $232,400 for January 2028 calls.
- Moderna and UnitedHealth Group saw bullish call sweeps with values of $28,200 and $35,600.
- Novo Nordisk and Regeneron recorded bearish call trades valued at $27,600 and $28,300.
Benzinga’s options scanner identified ten instances of large-scale trading in the healthcare sector during the recent session. The activity spanned various expiration dates and strike prices, with Hims & Hers Health recording the highest total trade value at $232,400 for January 2028 calls. Moderna and Unilever also saw notable sweep activity, indicating concentrated interest in these specific instruments.
The reported trades reflect divergent sentiment among market participants, with bullish positions concentrated in Moderna, Bioventus, and UnitedHealth Group. Conversely, bearish sentiment was evident in Novo Nordisk, Regeneron, and Intellia Therapeutics. These movements suggest that institutional investors are taking opposing views on the near-term trajectory of these companies, with some positioning for upside and others hedging against potential declines.
Largest Trades Center On Hims
The most significant financial commitment in the dataset was linked to Hims & Hers Health, where a single call option trade valued at $232,400 was executed. This transaction involved 406 contracts at a $50 strike price, expiring on January 21, 2028. The bearish sentiment tag attached to this trade indicates that the buyer likely used these calls as a hedge or the seller took a bearish view on the stock’s performance over the long term.
Avanos Medical followed with a bullish call sweep totaling $119,400 for 266 contracts at a $35 strike, expiring in January 2027. Intellia Therapeutics recorded a bearish call trade of $84,700 for 283 contracts at a $15 strike, also expiring in January 2028. These substantial figures highlight the level of conviction behind the positions, as traders are allocating significant capital to specific outcomes for these firms.
Moderna And Unilever Show Bullish Signals
Moderna experienced a bullish call sweep involving 100 contracts at a $180 strike, expiring on September 25, 2026. The total cost for this position was $28,200, with a per-contract price of $283.00. The trade required five separate executions to fill, suggesting aggressive buying pressure to secure the position quickly. Prior open interest at this strike was 863 contracts, indicating a shift in market positioning.
UnitedHealth Group saw a bullish call sweep of 117 contracts at a $270 strike, expiring on June 17, 2027, for a total of $35,600. Bioventus recorded a similar bullish sweep with 505 contracts at a $47 strike, expiring in October 2026, totaling $29,500. These trades suggest that investors are betting on sustained performance from these established healthcare entities over the coming months.
Bearish Positions Target Novo And Regen
Novo Nordisk was the subject of a bearish call trade involving 200 contracts at a $40 strike, expiring on October 16, 2026. The total value of this trade was $27,600, with a per-contract price of $138.00. Regeneron also saw bearish activity with a call sweep of nine contracts at a $160 strike, expiring in December 2026, totaling $28,300. The high per-contract price of $3,150 for Regeneron reflects the deep out-of-the-money nature of these positions.
Clover Health recorded a bullish call trade of 750 contracts at a $5 strike, expiring on January 15, 2027, for a total of $37,500. Prime Medicine saw a bullish call trade of 254 contracts at a $3 strike, expiring in January 2028, totaling $30,400. These transactions indicate that while some traders are bearish on large-cap pharmaceuticals, others are positioning for upside in smaller or mid-cap healthcare stocks.
